Magdalena Staniszewska is a professor at the John Paul II Catholic University of Lublin. She graduated with an M.Sc. from the Wrocław University of Technology and obtained a Ph.D. in biological sciences at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences. She completed a post-doctoral fellowship at Case Western Reserve University, Cleveland, OH, and Harvard Medical School, Boston, MA, USA. She is a leading biotechnology scientist with several years of experience at Harvard Medical School in Boston, MA (USA) and the Polish Academy of Sciences and is a scientist with broad experience in discovering molecular bases of diseases, identifying targets, and developing novel therapeutic strategies for diabetic complications, cancer, and eye diseases. She has also co-invented analytical tools and diagnostic markers of pathological neovessels, and holds a track record of scientific publications and public speaking.
Magdalena Staniszewska is a professor at the John Paul II Catholic University of Lublin. She graduated with an M.Sc. from the Wrocław University of Technology and obtained a Ph.D. in biological sciences at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences. She completed a post-doctoral fellowship at Case Western Reserve University, Cleveland, OH, and Harvard Medical School, Boston, MA, USA. She is a leading biotechnology scientist with several years of experience at Harvard Medical School in Boston, MA (USA) and the Polish Academy of Sciences and is a scientist with broad experience in discovering molecular bases of diseases, identifying targets, and developing novel therapeutic strategies for diabetic complications, cancer, and eye diseases. She has also co-invented analytical tools and diagnostic markers of pathological neovessels, and holds a track record of scientific publications and public speaking.